Alexion Pharma International SARL
Part of Alexion Pharmaceuticals Inc.
- UEI
- FKJ6ZGM5A7P7
- CAGE
- SSF77
- Primary NAICS
- Not on record
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
Boston, MA
DKCXLGANZAN3
-
Parent
Boston, MA
DKCXLGANZAN3
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Phase 2 study of ENB-0040 for the treatment of hypophosphatasia | Food and Drug Administration | $1,200,000 |
Quick answers
Is Alexion Pharma International SARL registered in SAM.gov?
Alexion Pharma International SARL's SAM.gov registration expired on May 13, 2015.
What is Alexion Pharma International SARL's most recent federal award?
Alexion Pharma International SARL's most recent federal grant award is Phase 2 study of ENB-0040 for the treatment of hypophosphatasia (R01FD003745), from Food and Drug Administration, on June 20, 2011.
On GovTribe
See Alexion Pharma International SARL's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors